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Introduction 
The recent update summary of tetrahydrobio-
pterin deficiency due to autosomal recessive mu-
tations in 6-pyruvoyl-tetrahydropterin synthase 
(PTPS) compiled 186 cases in total, i.e. 156 cases 
with the more common severe form and 30 cases 
with the rare mild or peripheral form (1). Pa-
tients with the mild type of deficiency, as opposed 
to the severe form, do not show any ab-
normalities of monoamine neurotransmitter meta-
bolites in CSF and thus do not require re-
placement therapy with L-DOPA and 5-0H-typ-
tophan. Genetic as well as biochemical properties 
of the normal human PTPS in comparison with 
mutant alleles might be a key to the understanding 
of these phenotypical differences. As an example, 
tissue-specific splicing was uncovered for the Dro-
sophila purple gene that expresses the fly PTPS ac-
tivity (2). The single purple gene was shown to ex-
press two transcripts with the same putative cod-
ing region from two different promoters; i.e. a 
weak constitutive body promoter and a strong 
transient head-specific promoter, expressing the 
alternatively spliced mRNAs with exon structures 
a-bl-c-d-e and b2-c-d-e, respectively. In-
terestingly, the molecular characterization of the 
first patient with the mild form of PTPS de-
ficiency revealed one allele, RI6C, with the cor-
responding mutation located in exon 1 in the sin-
gle human gene (3,4). In the case of a similar tis-
§ Author to whom correspondence should be addressed. 
sue-specific splicing as observed for the Dro-
sophila purple gene, a brain-specific, non-mutated 
5 I exon might be present in the human neuronal 
PTPS-cDNA. 
In this work we addressed the question wheth-
er the brain-specific form (s) of the human PTPS-
cDNA is identical to the liver-specific form. We 
first isolated PTPS-cDNAs from human brain li-
braries by using the liver-specific cDNA as a 
probe. As we did not find any clones with 5 '-ends 
comparable to the known liver cDNA, we applied 
RACE technology to examine 5 I -stretches from 
freshly prepared RNA of neuronal cells expressing 
the active PTPS enzyme. Analysis of these am-
plified cDNAs revealed that the neuron-specific 
PTPS was identical to the liver-specific form. 
These findings argue against e.g. tissue-specific 
splicing as a molecular mechanism to develp the 
rare peripheral form of PTPS deficiency as op-
posed to the more common central form. 
Materials and Methods 
Screening of Agtll-vector derived human brain 
cDNA libraries (hypothalamus 5 '-stretch, Clon-
tech HL1l72b and Alzheimer patient, Clontech 
HLI 028) was carried out following conventional 
protocols. As a probe, the human liver PTPS-
eDNA was hybridized at a temperature of 62°C. 
To isolate 5' ends of the PTPS eDNA, a stan-
dard protocol describing the 'rapid amplification of 
cDNA ends' (5 ' -R..-\CE ) by Frohman et al. was ap-
plied (5). The two PTPS-specific primers PTPS7B 
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(5'-GGCACATCCATATCCAG-3') and PTPS9 
( 5 ' - C G G GAT C C G G G G C T G CAT AA-
TCGCCTCC-3 ') were used for the first and 
second round, respectively, of PCR amplification. 
As a template, we used reverse transcribed total 
RNA (2 j..Lg) prepared from the cultured human 
neuroblastoma cells SK-N-BE. Restriction frag-
ments from positive A-phage clones or from 5'-
RACE products were cloned into pUC18/ 19 
plasmids and sequenced using the AutoRead 
sequencing kit and an Automated Laser Flu-
orescent (A.L.F.) DNA sequencer from Pharmacia 
Biotech. 
Results and Discussion 
Previous Western blot analysis of PTPS-cross-
reactive material in extracts from human brain tis-
sues (hypothalamus, mesencephalon, hypophysis) 
and the neuroblastoma cell line SK-N-BE sug-
gested the presence of the same PTPS in neu-
ronal tissue as in human liver cells or fibroblasts. 
Similarly, Northern blot analysis of human SK-N-
BE (neuroblastoma cells), Hep G2 (hepatoma 
cells) and fibroblasts showed no difference in 
PTPS transcript size between the different RNA 
extracts (unpublished observations). Nevertheless, 
we performed extensive screening of two comm-
ercially available human brain cDNA libraries, Al-
zheimer patient and hypothalamus, with the liver 
PTPS-cDNA as a probe and isolated three clones 
with different 5'-and 3'-ends (Fig. 1). Apart from 
the fact that none of these isolated had a poly-A 
tail, each exhibited a different length of its 3 '-end. 
While the longest clone had an extension of 415 
bp downstream from the TAG stop codon, the 
two other clones matched either the previous 
cDNA isolates from liver (6 ) or leukemia cells (7) 
with an extension of 198 bp and 249 bp, respec-
tively, of untranslated DNA. Comparison of the 3' 
untranslated sequence of the PTS gene revealed 
that the entire 415 bp are part of exon 6 . Moreov-
er, polyadenylation signals, a classical (AATAAA) 
and a non-classical (ATTAAA), were present 15 
bp and 16 bp upstream of the 3' end of the 
clones with the 415 bp and 249 bp non-coding 
DNA, respectively. These findings suggest that up 
to 3 different 3' -ends of the PTPS transcript may 
be present in neuronal and other human tissues. 
Regarding the 5'-ends of the cDNA library iso-
lates, the two longer clones were deleted for exon 
3 , and only one extended into exon 1. A deletion 
of the 23 bp in the PTPS-cDNA, comprising 
exon 3 on genomic DNA, leads to a frame shift 
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Figure 1 . Organization of the human PTS gene and ex-
tension of corresponding cDNA clones isolated from 
various sources. The PTS gene located on chromosome 
11q 22.3-q23.3 is composed of 6 exons asincticated by 
the boxes. The coding regions are in black, whereas the 
5' -and 3'-untranslated stretches are depicted as open 
bars. The position of the two putative polyadenylation 
signals (ATTAAA and AATAAA) are incticated by arrows . 
The different sources of inctividual cDNA isolates are 
given on the right. Polyadenin stretches found at the 3'-
ends of cDNAs are incticated by 'polyA' . The hatched 
box is a spliced fragment which originates from intron 1 
(see text for details) . For comparison, the extension of 
the 74%-identiy to the PTS-Pl retropseudogene is given 
at the bottom. 
and a subsequent stop codon. A similar mutant 
cDNA allele has been isolated previously from a 
PTPS patient (K54X allele; 8). The cause for ex-
pressing such a mutant RNA was a genomic T to 
A transversion at position-7 in the 3 '-acceptor 
splice site of the patient 's intron 2, which leads to 
exon 3 skipping (4). Interestingly, a sequence 
alignment between the liver PTPS cDNA and the 
PTS-Pl retropseudogene revealed a significant 
homology gap of 23 bp extending over the exon 3 
region . This implicates that exon 3 skipping does 
not occur exclusively due to 3 '-acceptor splice mu-
tations, but might also be caused by a splicing po-
lymorphism. 
In addition to a deletion of exon 3, we found 
in one clone from the hypothalamus cDNA li-
brary a DNA fragment which was fused at the 5 ,-
end of exon 2. This fragment turned out to be an 
internal 226 bp stretch from intron 1 (nucleotide 
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poslt:J.on 1451-1676 in the deposited GenBank se-
quence L76259). This cDNA clone, which is a 
splice product consisting of the 226 bp 'exonic' 
fragment plus exons 2, 4, 5 and 6, did also not 
yield any open reading frame in its 5 I -portion of 
the cDNA. 
Although at this stage we could not exclude 
any functional role for the isolated brain cDNA 
clones, we assumed that the exon 3 deletion in 
two clones and the spliced fragment from intron 
1 in one clone were due to some artifacts 
present in the neuronal cDNA libraries analyzed. 
Furthermore, as we detected PTPS enzyme ac-
tivity (9) and cross-reactive material in human 
hypothalamus extract (not shown), we expected 
to find a cDNA that encodes a functional PTPS. 
To discriminate between erroneously spliced 
cDNAs present in the brain cDNA libraries and 
potentially alternative splicing in neuronal cells, 
we carried out 5 ' -RACE experiments with fresh-
ly prepared RNA from cultured · neurobla-
stoma cells that expressed the human PTPS en-
dogenously (SK-N-BE cells, unpublished ob-
servation) . The PTPS-specific downstream prim-
ers were selected to amplifY the cDNA upstream 
from exon 5 (PTPS7B and PTPS9; for details 
see Materials and Methods). The 5 '-RACE pro-
ducts were gel purified, subcloned into plasmid 
vectors, and sequenced. The two clones that we 
analyzed did neither show any alternatively splic-
ed forms of PTPS-cDNA, nor a deletion of exon 
3 (Fig. 1). Furthermore, one clone had the com-
plete coding sequence of exon 1 plus 18 bp of 
the non-coding 5 ' -upstream sequence. Un-
fortunately, we did not isolate any clones that 
were extended up to the previously described 68 
bp upstream from the translational start site 
(Ashida et ai., 1993). 
In summary, our findings argue against alt-
ernative 5 '-exons in the human PTS gene for ex-
pression of a functional enzyme, since no such tis-
sue- or cell-specific transcripts for the human 
PTPS were isolated . Whether the occurrence of a 
deletion of exon 3 in processed transcipts is a po-
lymorphism or has some functional meaning ne-
eds to be clarified. Furthermore, to unravel the 
molecular basis of clinical and biochemical diff-
erences of the various forms of PTPS insufficiency, 
more data about the molecular defects in patients 
especially with the peripheral type of PTPS de-
ficiency are required. 
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